Answers are grounded in this paper and cite their sources.
Menopause is frequently associated with sexual dysfunction, reduced sexual satisfaction, and impaired sexual quality of life due to hormonal, physical, and psychological changes. Considering the increasing interest in complementary and herbal therapies, this study aimed to evaluate the effect of date palm pollen supplementation on sexual function, sexual satisfaction, and sexual quality of life among postmenopausal women. This double-blind randomized clinical trial was conducted on 130 postmenopausal women(65 participants in each group) who were randomly assigned to either an intervention group receiving date palm pollen supplementation or a placebo control group. Baseline demographic and clinical characteristics were assessed before the intervention. Sexual function, sexual satisfaction, and sexual quality of life were evaluated at baseline, one month, and two months after the intervention using validated questionnaires. Because the outcome variables were not normally distributed, nonparametric longitudinal analysis using the nparLD package in R was performed to assess group, time, and group × time interaction effects. The mean age of participants was 52.3 ± 3.1 years. Significant group × time interaction effects were observed for female sexual function, sexual satisfaction, and sexual quality of life (all p < 0.001), indicating different patterns of change between groups. In the intervention group, median (IQR) scores increased from baseline to two months for sexual function (18.5 [16.3–19.8] to 26.2 [25.1–27.9]), sexual satisfaction (84 [78.5–90] to 106 [99–109]), and sexual quality of life (71 [59–81] to 91.5 [79.7–99]). In contrast, scores in the control group remained relatively stable or slightly decreased, indicating greater improvements in all outcomes in the intervention group. Date palm pollen supplementation was associated with improvements in sexual function, satisfaction, and sexual quality of life; however, findings should be interpreted cautiously due to baseline imbalances and short follow-up. Further randomized clinical trials with larger sample sizes, longer follow-up periods, standardized dosages, and hormonal assessments are recommended to confirm the long-term efficacy and safety of this intervention. Iranian Registry of Clinical Trials, IRCT20241204063940N1. Registered on 22 June 2025.
No takes yet. Share an insight, caveat, or question.
Aali et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: